Results 51 to 60 of about 2,007 (218)

Hematinic deficiencies and anemia statuses in anti-gastric parietal cell antibody-positive or all autoantibodies-negative erosive oral lichen planus patients

open access: yesJournal of the Formosan Medical Association, 2018
Approximately 27% of erosive oral lichen planus (EOLP) patients have serum anti-gastric parietal cell antibody (GPCA) positivity. This study assessed whether serum GPCA or EOLP itself was a significant factor that caused hematinic deficiencies and anemia
Julia Yu-Fong Chang   +5 more
doaj   +1 more source

Antianemic Potential of Artocarpus chaplasha Seeds in Phenyl Hydrazine–Induced Hemolytic Anemia: Evidence From Swiss Albino Mice and Molecular Docking Studies

open access: yesAdvances in Pharmacological and Pharmaceutical Sciences, Volume 2026, Issue 1, 2026.
Background and Aim Anemia affects billions, primarily young women and men. Taking steroids and immunosuppressants might cause side effects. So recent studies are focusing on natural hematinic agents to cure anemia. This study examined Artocarpus chaplasha seeds against phenyl hydrazine–induced hemolytic anemia in Swiss albino mice.
Nazratun Noor Maria   +7 more
wiley   +1 more source

Pharmaceuticals, except biologicals : 2008 [PDF]

open access: yes, 2009
Current industrial report.

core  

Severe anemia in Malawian children [PDF]

open access: yes, 2008
Background Severe anemia is a major cause of sickness and death in African children, yet the causes of anemia in this population have been inadequately studied.
Bates, Imelda   +18 more
core   +2 more sources

Hematin Therapy for Acute Porphyria

open access: yesMedicine, 1979
1. A therapeutic trial of intravenous hematin is presented. Eleven cases of AIP and one of VP who did not improve with conventional treatment (high carbohydrate intake) received this new agent. 2. Urinary ALA, PBG and, when possible, uroporphyrin and coproporphyrin were used to monitor the chemical response to the treatment.
J M, Lamon   +3 more
openaire   +2 more sources

Advanced Lymphoblastic Lymphoma, NOS in Leukaemic Phase Presenting With Sudden and Fatal CNS Haemorrhage

open access: yesCase Reports in Pathology, Volume 2026, Issue 1, 2026.
B/T‐lymphoblastic lymphoma (LBL), not otherwise specified (NOS), is a rare precursor lymphoid neoplasm that exists along a biological spectrum with acute lymphoblastic leukaemia (ALL). Although traditionally distinguished by the extent of bone marrow involvement, this separation becomes increasingly blurred in advanced or leukaemic presentations ...
Emmanuel Kissiedu Antiri   +3 more
wiley   +1 more source

Formulation and standardization of lohasava: an ayurvedic aasava formulation Man

open access: yesJournal of Applied Pharmaceutical Research
Background: Plant solutions or decoctions are fermented with added sugar to create alcoholic remedies like arishta and aasava. Standardizing ayurvedic formulations is essential to assessing the quality of medicine. Objective: Standardisation of Lohasava,
Manisha A. Tayde   +4 more
doaj   +1 more source

Anemia, hematinic deficiencies, and hyperhomocysteinemia in gastric parietal cell antibody-positive and -negative atrophic glossitis patients

open access: yesJournal of the Formosan Medical Association, 2019
Background/Purpose: Approximately 27% of atrophic glossitis (AG) patients have the serum gastric parietal cell antibody (GPCA) positivity. This study assessed whether the serum GPCA or AG itself was a significant factor causing anemia, hematinic ...
Chun-Pin Chiang   +5 more
doaj   +1 more source

Pharmaceuticals, except biologicals : 2009 [PDF]

open access: yes, 2010
Current industrial report.

core  

Extreme ameloblastoma of the mandible with hypoproteinemia: a case report and review of clinicopathological features [PDF]

open access: yes, 2011
Ameloblastoma is a tumor of odontogenic epithelium. It has an intermediate malignant potential, thus positioning it in a gray zone between benign and malignant neoplasms. Invasive ameloblastomas of excessive size are rarely confronted.
Acharya, Swetha   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy